These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9466158

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up.
    Prasko J, Dockery C, Horácek J, Houbová P, Kosová J, Klaschka J, Pasková B, Praskova H, Seifertová D, Záleský R, Höschl C.
    Neuro Endocrinol Lett; 2006 Aug; 27(4):473-81. PubMed ID: 16891998
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Personality traits in social phobia, II: Changes during drug treatment.
    Fahlén T.
    J Clin Psychiatry; 1995 Dec; 56(12):569-73. PubMed ID: 8530333
    [Abstract] [Full Text] [Related]

  • 5. What happens to patients after the end of a clinical trial? Systematic follow-up observational study of an open moclobemide trial in major depression.
    Linden M, Baier D, Gothe H, Kohnen R.
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):35-43. PubMed ID: 9035226
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP, Tsoi WF.
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of augmentation with moclobemide on symptoms of schizophrenia.
    Silver H, Aharon N, Hausfater N, Jahjah N.
    Int Clin Psychopharmacol; 1999 May; 14(3):193-5. PubMed ID: 10435775
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nefazodone for social phobia: a clinical case series.
    Worthington JJ, Zucker BG, Fones CS, Otto MW, Pollack MH.
    Depress Anxiety; 1998 May; 8(3):131-3. PubMed ID: 9836065
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Moclobemide in the treatment of social phobia.
    Nutt D, Montgomery SA.
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():77-82. PubMed ID: 8923114
    [Abstract] [Full Text] [Related]

  • 19. Endoscopic sympathetic block--new treatment of choice for social phobia?
    Pohjavaara P, Telaranta T, Väisänen E.
    Ann Chir Gynaecol; 2001 Jun; 90(3):177-84. PubMed ID: 11695789
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.